Terms: = Pancreatic cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Clinical Outcome
19 results:
1. clinical outcome and Treatment Sequences of Patients with Advanced pancreatic cancer Treated with Contemporary Chemotherapy Protocols.
Roehrle J; Kasper S; Treckmann JW; Markus P; Schumacher B; Albers D; Wendling J; Ting S; Mende B; Maßmann M; Markus M; Virchow I; Rosery V; Laue K; Zaun G; Kostbade K; Pogorzelski M; Reissig TM; Liffers ST; Schmid K; Schildhaus HU; Schuler M; Siveke JT; Wiesweg M
Oncol Res Treat; 2023; 46(4):140-150. PubMed ID: 36720216
[TBL] [Abstract] [Full Text] [Related]
2. Impact of Modern Management Strategies on the clinical outcome of Patients With Low Rectal cancer - A Retrospective, Monocentric Cohort Study.
Karam E; Sindayigaya R; Giger-Pabst U; Gabriel M; Michot N; Courtot L; Tabchouri N; Moussata D; Lecomte T; Chapet S; Calais G; Bourlier P; Salamé E; Ouaissi M
Anticancer Res; 2022 Apr; 42(4):1949-1963. PubMed ID: 35347015
[TBL] [Abstract] [Full Text] [Related]
3. Accuracy and other quality indicators of solid pancreatic mass endoscopic ultrasound-guided fine needle aspiration and biopsy in two academic endoscopy centers.
Figueiredo M; Arvanitakis M; Zaarour A; Toussaint E; Devière J; Van Laethem JL; Gomez-Galdon M; Verset L; Demetter P; Eisendrath P
Acta Gastroenterol Belg; 2021; 84(3):451-455. PubMed ID: 34599570
[TBL] [Abstract] [Full Text] [Related]
4. LINE-1 methylation level and prognosis in pancreas cancer: pyrosequencing technology and literature review.
Yamamura K; Kosumi K; Baba Y; Harada K; Gao F; Zhang X; Zhou L; Kitano Y; Arima K; Kaida T; Takeyama H; Higashi T; Imai K; Hashimoto D; Chikamoto A; Tan X; Baba H
Surg Today; 2017 Dec; 47(12):1450-1459. PubMed ID: 28536860
[TBL] [Abstract] [Full Text] [Related]
5. Enucleation versus hepatectomy for giant hepatic haemangiomas: a meta-analysis.
Cheng WL; Qi YQ; Wang B; Tian L; Huang W; Chen Y
Ann R Coll Surg Engl; 2017 Mar; 99(3):237-241. PubMed ID: 27869486
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection.
Chan AW; Chan SL; Wong GL; Wong VW; Chong CC; Lai PB; Chan HL; To KF
Ann Surg Oncol; 2015 Dec; 22(13):4138-48. PubMed ID: 25801356
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen.
Bruera G; Cannita K; Giordano AV; Vicentini R; Ficorella C; Ricevuto E
Int J Oncol; 2014 Jun; 44(6):1820-30. PubMed ID: 24715238
[TBL] [Abstract] [Full Text] [Related]
8. Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients.
Szkandera J; Stotz M; Absenger G; Stojakovic T; Samonigg H; Kornprat P; Schaberl-Moser R; Alzoughbi W; Lackner C; Ress AL; Seggewies FS; Gerger A; Hoefler G; Pichler M
Br J Cancer; 2014 Jan; 110(1):183-8. PubMed ID: 24201751
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).
Martin-Perez E; Capdevila J; Castellano D; Jimenez-Fonseca P; Salazar R; Beguiristain-Gomez A; Alonso-Orduña V; Martinez Del Prado P; Villabona-Artero C; Diaz-Perez JA; Monleon A; Marazuela M; Pachon V; Sastre-Valera J; Sevilla I; Castaño A; Garcia-Carbonero R
Neuroendocrinology; 2013; 98(2):156-68. PubMed ID: 23988576
[TBL] [Abstract] [Full Text] [Related]
10. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
[TBL] [Abstract] [Full Text] [Related]
11. The usefulness of S100P, mesothelin, fascin, prostate stem cell antigen, and 14-3-3 sigma in diagnosing pancreatic adenocarcinoma in cytological specimens obtained by endoscopic ultrasound guided fine-needle aspiration.
Dim DC; Jiang F; Qiu Q; Li T; Darwin P; Rodgers WH; Peng HQ
Diagn Cytopathol; 2014 Mar; 42(3):193-9. PubMed ID: 21538952
[TBL] [Abstract] [Full Text] [Related]
12. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
[TBL] [Abstract] [Full Text] [Related]
13. Short tandem repeat polymorphisms of exon 4 in Kazal-type gene ECRG2 in pancreatic carcinoma and chronic pancreatitis.
Kaifi JT; Cataldegirmen G; Wachowiak R; Schurr PG; Kleinhans H; Kosti G; Yekebas EF; Mann O; Kutup A; Kalinin V; Strate T; Izbicki JR
Anticancer Res; 2007; 27(1A):69-73. PubMed ID: 17352218
[TBL] [Abstract] [Full Text] [Related]
14. Multianalyte profiling of serum cytokines for detection of pancreatic cancer.
Zeh HJ; Winikoff S; Landsittel DP; Gorelik E; Marrangoni AM; Velikokhatnaya L; Winans MT; Lee K; Moser A; Bartlett D; Lotze MT; Siegfried JM; Whitcomb D; Papacristou G; Slivka A; Bigbee WL; Lokshin AE
Cancer Biomark; 2005; 1(6):259-69. PubMed ID: 17192050
[TBL] [Abstract] [Full Text] [Related]
15. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer.
Li D; Frazier M; Evans DB; Hess KR; Crane CH; Jiao L; Abbruzzese JL
J Clin Oncol; 2006 Apr; 24(11):1720-8. PubMed ID: 16520463
[TBL] [Abstract] [Full Text] [Related]
16. CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.
Duxbury MS; Matros E; Clancy T; Bailey G; Doff M; Zinner MJ; Ashley SW; Maitra A; Redston M; Whang EE
Ann Surg; 2005 Mar; 241(3):491-6. PubMed ID: 15729073
[TBL] [Abstract] [Full Text] [Related]
17. Management of cancer of the ampulla of Vater: does local resection play a role?
Lindell G; Borch K; Tingstedt B; Enell EL; Ihse I
Dig Surg; 2003; 20(6):511-5. PubMed ID: 14506332
[TBL] [Abstract] [Full Text] [Related]
18. Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary strictures.
Farrell RJ; Agarwal B; Brandwein SL; Underhill J; Chuttani R; Pleskow DK
Gastrointest Endosc; 2002 Nov; 56(5):681-7. PubMed ID: 12397276
[TBL] [Abstract] [Full Text] [Related]
19. clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction.
Yim HB; Jacobson BC; Saltzman JR; Johannes RS; Bounds BC; Lee JH; Shields SJ; Ruymann FW; Van Dam J; Carr-Locke DL
Gastrointest Endosc; 2001 Mar; 53(3):329-32. PubMed ID: 11231392
[TBL] [Abstract] [Full Text] [Related]
